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One-hundred and two patients with hemophilia A, hemophilia
B, or acquired antibody to factor VIII who had undergone invasive
procedures were cross referenced with patients participating in
an ongoing prospective natural history study of HIV-1 infection
in hemophiliacs. Matching revealed that HIV-1 status was known
for 83 patients (83%) who had undergone 169 procedures between
July 1979 and April 1988. Invasive procedures were classified
as clean in 108 patients (63.9%), clean-contaminated in 45
(26.6%), contaminated in 2 (1.2%), and infected in 14 (8.3%).
Wound infection rates by HIV-1 status were as follows (95%
confidence intervals): HIV+ 1.4% (0% to 5%), HIV- 0% (0%
to 9%), and procedure before testing HIV+ 1.5% (0% to 6%).
There were no significant differences between the wound infection
rates of HIV-positive and HIV-negative hemophiliacs nor in the
wound infection rate among all three subgroups of patients (p
> 0.5, Fisher's Exact Test). We conclude that surgery in HIV-
1-infected patients who have not progressed to AIDS does not
entail an increased risk of postoperative wound infections.
P5 ATIENTS INFECTED WITH the human immuno-
deficiency virus who have developed the acquired
immunodeficiency syndrome (AIDS) or AIDS-
related complex (ARC) appear to have an increased in-
cidence of a variety ofbacterial infections."2 Disseminated
atypical mycobacterial infection was recognized early in
the HIV- 1 epidemic as a manifestation of AIDS.3-5 More
recently infection with M. tuberculosis has been reported
in 5% to 10% of AIDS patients studied in retrospective
series.6-'0 Patients with AIDS have also been reported to
have increased susceptibility to a variety ofother bacterial
pathogens including Salmonella, Listeria, Streptococcus
pneumonia, Haemophilus influenzae, Branhamella ca-
tarrhalis, Campylobacter jejuni, Campylobacter-like or-
ganisms, and Shigella.",2
Address correspondence to David Jay Weber, M.D., M.P.H., CB 7030
Burnett-Womack 229H, Division ofInfectious Diseases, UNC at Chapel
Hill, Chapel Hill, NC 27599-7030.
Reprints will not be available.
Accepted for publication August 2, 1989.
From the Division of Trauma and Critical Care, * Department
of Surgery; Divisions of Infectious Diseasest and
Hematology,f Department of Medicine, University of North
Carolina at Chapel Hill; and Department of Hospital
Epidemiology, University of North Carolina Hospital,§
Chapel Hill, North Carolina
HIV- 1-infected patients undergo routine surgery as well
as diagnostic and therapeutic procedures for complications
oftheir immunodeficiency. Operative risks, including that
ofnosocomial infections, in HIV- 1-infected patients who
have not progressed to AIDS are unknown. These persons
(Centers for Disease Control [CDC] class II) represent the
largest group ofthe estimated 1.5 million HIV- 1-infected
persons in the United States."1"12 There is reasonable con-
cern about indications and risks in operating on clinically
asymptomatic HIV-infected patients because many have
demonstrable subclinical immune dysfunction on labo-
ratory testing or anergy by skin testing. Such impaired
immune function might increase the risk ofperioperative
infection, including wound infection.
To determine if HIV- 1-infected patients, before the
development ofARC or AIDS, were at increased risk for
the development of postoperative wound infections, we
compared the operative risks of HIV- 1-infected hemo-
philiacs with those ofnon-HIV- 1-infected hemophiliacs.
Methods
This study was conducted at the University of North
Carolina Hospital, a 600-bed acute-care hospital that
serves as the main teaching hospital for the University of
North Carolina School of Medicine at Chapel Hill. Nos-
ocomial infection surveillance of all hospital patients is
conducted by three full-time infection-control practitio-
ners and directed by two staffmembers from the Division
of Infectious Diseases.
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As part of a natural history study, HIV-1 testing has
been offered to all hemophiliacs currently under care at
the University of North Carolina Comprehensive He-
mophilia Diagnostic and Treatment Center (see Smiley
et al.'3 for details). HIV-1 status was determined by West-
ern Blot analysis. We confined our study to patients with
hemophilia A (deficiency of clotting factor VIII), hemo-
philia B (deficiency of clotting factor IX), and patients
with an inhibitor (acquired antibody to factor VIII). The
degree of hemophilia was classified as severe (< 1% ofthe
normal clotting factor activity in the blood), moderate
(1% to 5% of the normal clotting factor activity in the
blood), or mild (more than 5% of the normal clotting
factor activity in the blood).
Using a computerized retrieval system in Medical Rec-
ords, we ascertained all patients with hemophilia A or B
who underwent invasive procedures between July 1978
and April 1988. Charts of all hemophilia patients under-
going invasive procedures were reviewed independently
by an infection control practitioner and a surgeon, and
coded for type of procedure, date of procedure, compli-
cations including bleeding or hematoma, and develop-
ment of wound or nosocomial infection. Medical evalu-
ation after invasive procedure is standard for all hemo-
philiacs cared for at the Comprehensive Hemophilia
Diagnostic and Treatment Center and was available for
all subjects. Procedures were defined as clean, clean-con-
taminated, contaminated, or infected using CDC cri-
teria.'4 Chart reviewers were blinded as to the HIV-1 status
of the patient, although at times this information was re-
corded in the chart.
The HIV- I status at the time of procedure was retro-
spectively coded as known or unknown. Patients with a
known HIV-1 status included patients with procedures
subsequent to a positive HIV- 1 test (HIV+) and patients
with procedures before a negative HIV- 1 test (HIV-). Data
also were accumulated on patients with an unclear HIV-
1 status who had undergone procedures before a positive
HIV-1 test (pre-HIV+).
T4-lymphocyte subset analysis was performed in the
Hematology Laboratory, University of North Carolina
Hospital. T4 levels were performed on many patients at
6- to 12-month intervals beginning in 1983. For proce-
dures performed before 1983, the T4 level obtained in
1983 was used in our analysis. For procedures performed
after 1983, the T4 level obtained most closely in time to
the procedure was used, provided that the T4 level was
obtained within 6 months of the procedure.
For the purpose of this study the outcome variable of
major interest was wound infections. Ifpatients underwent
multiple procedures, each procedure's risk of infection
was considered an independent event. T4-lymphocyte
levels among patient groups (HIV-, pre-HIV+, HIV+
pre-AIDS, HIV+ AIDS) were compared using an analysis
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of variance on the ranks of the raw data (i.e., equivalent




As of July 1987, HIV-1 status was known on 276 pa-
tients with hemophilia A or B. The likelihood of being
HIV positive correlated with severity of hemophilia. For
patients with hemophilia A, the number ofpatients testing
HIV positive over the patient population was as follows:
severe clotting factor deficiency 126 of 162 patients
(77.8%), moderate clotting factor deficiency 2 of 6 patients
(33.3%), and mild clotting factor deficiency 4 of41 patients
(9.8%). For patients with hemophilia B, the number of
patients testing HIV positive over the patient population
was as follows: severe clotting factor deficiency 13 of 30
patients (43.3%), moderate clotting factor deficiency 0 of
3 patients (0%), and mild clotting factor deficiency 1 of
8 patients (12.5%). Seven of twenty-six patients (26.9%)
with acquired antibody to factor VIII were HIV- 1 positive.
One hundred two hemophilia patients who underwent
invasive procedures were ascertained by retrospective re-
view of the medical records. Charts were available for
review on 100 patients (98%). Comparison of these pa-
tients with our ongoing prospective natural history study
revealed that HIV-1 status was known for 83 patients
(83%) who had undergone 169 procedures (average of 2
procedures per patient) between July 1979 and April 1988.
HIV- 1-positive hemophiliacs in our study had more
severe clotting factor deficiency than HIV- 1-negative he-
mophiliacs (Table 1). Patients classified as pre-HIV pos-
itive were similar to HIV-positive patients in regard to
their type and severity of hemophilia. The time intervals
between the invasive procedure and positive HIV- 1 test
for the pre-HIV-positive group were as follows (cumu-
lative %): less than 1 year, 9 patients (13%); 1 to 2 years,
17 patients (39%); 2 to 3 years, 13 patients (58%); 3 to 4
years, 5 patients (66%); 4 to 5 years, 8 patients (78%); 5
to 6 years, 7 patients (88%); and more than 6 years, 8
patients (100%).
Invasive procedures undergone by patients in our study
were classified as clean, 108 patients (63.9%); clean-con-
taminated, 45 patients (26.6%); contaminated, 2 patients
(1.2%); and infected, 14 patients (8.3%) (Table 2). The
most common clean procedures were orthopedic recon-
structions.
Wound Infection Rates
There were only two cases of postprocedural wound
infection in these 169 procedures (Table 3). Wound in-
fection rates by HIV-1 status were as follows (95% con-
Vol. 211 * No. 4
494 BUEHRER AND OTHERS
TABLE 1. Type and Severity ofHemophilia By HIV Status
HIV- Pre-HIV+ HIV+
Hemophilia Pt* IPt Pt IP Pt IP
Severe VIII deficiency 6 7 33 61 38 64
Moderate VIII deficiency 2 2 1 1 0 0
Mild VIII deficiency 5 8 0 0 0 0
Severe IX deficiency 4 5 1 2 2 2
Moderate IX deficiency 1 1 0 0 0 0
Mild IX deficiency 1 2 1 1 1 1
Inhibitor 4 6 2 2 2 4
Total 23 31 38 67 43 71
* Number of patients. t Number of invasive procedures.













































Performed in Patients fidence intervals): HIV positive, 1.4% (0% to 5%); HIV
'Status negative, 0% (0% to 9%); and pre-HIV positive, 1.5% (0%
[IV- Pre-HIV+ HIV+ to 6%). There were no significant differences between the
wound infection rates of HIV-positive and HIV-negative
hemophiliacs nor in the wound infection rates comparing
o 11 3 any two subgroups of patients (p > 0.5, Fisher's Exact
o 7 2 Test).
3 12 3 By April 1988, 12 of the 43 HIV-positive patients who
2 3 7 had undergone invasive procedures had progressed to
I 1 2 AIDS. Two patients developed AIDS in 1985, 2 in 1986,
3 5 0 6 in 1987, and 2 in the first 4 months of 1988. Ofthe 71
o 1 9 procedures performed in HIV-positive patients, seven
o o were done after the patients were classified as having
AIDS. Bleeding complications were noted in four ofthese
200 seven procedures, but no wound infections complicated







2 3 Bleeding Complications
3 0 Clinically significant bleeding and/or wound hemato-o o
0 o mas occurred during many of the procedures. Rates of
I 0 these complications by HIV- 1 status were as follows (95%
2 confidence intervals): HIV positive, 14% (7% to 23%); HIV
negative, 19% (8% to 35%); and pre-HIV positive, 18%
10 3 (10% to 28%). There were no significant differences in the
2 5 rate of clinical bleeding and/or hematoma formation be-
1 6 tween patients who were HIV positive or HIV negative,

















0 3 Four patients died within 30 days of their procedure.
0 2 HIV- 1 status at the time of death was as follows: HIV
negative, HIV positive pre-AIDS 1, HIV positive AIDS
0 1 2. Of the two patients with AIDS, one died from a gas-1 2
0 1 trointestinal hemorrhage during a hospitalization in which
I 0 a left hip prosthesis was removed due to infection with
I 0 Staphylococcus aureus and the other died of Pneumocys-
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TABLE 3. Wound Infections and Clinically Signifcant Bleeding Resultingfrom Invasive Procedures in Patients Stratified by HIV Status
HIV- Pre-HIV+ HIV+
Invasive Procedure IP* WIt BLt IP WI BL IP WI BL
Clean 18 0 4 49 1 10 41 0 5
Clean-contaminated 13 0 2 13 0 1 19 1 4
Contaminated 0 0 0 1 0 0 1 0 0
Infected 0 0 0 4 0 1 10 0 1
Total 31 0 6 67 1 12 71 1 10
* Number of invasive procedures. t Number of procedures complicated by bleeding.
t Number of wound infections.
titis carinii pneumonia during a hospitalization in which out the United States, reflecting the national distribution
a tracheostomy was performed. Causes of death for the of clotting factor concentrates they received before 1985.
remaining two patients were presumed illicit narcotic Seropositivity is related to the type and severity of coag-
overdose and an anteroseptal myocardial infarction. ulation disorder. 12 Overall about 70% of persons with he-
mophilia A and 35% with hemophilia B are seropositive.
T4-Lymphocyte Subset Analysis Within each type of hemophilia, seropositivity increases
with the severity of factor deficiency and, hence, with the
T4-lymphocyte subset analysis was available on many amount of clotting factor received.16 Among the 407 cases
patients (Table 4). T4 levels around the time of surgery of hemophilia-associated AIDS reported to the CDC by
in order of decreased mean levels were as follows: HIV September 1987, the distribution of specific opportunistic
negative, 622; pre-HIV positive, 518; HIV positive pre- infections and tumors, with the exception of significantly
AIDS, 335; and AIDS, 139. Although these values were fewer reports of Kaposi's sarcoma, was similar to ho-
all statistically different, the patient's HIV-1-infection . . '' . .............. . mosexual-associated and intravenous drug user-associated
status accounted for only about 20% of the variability in AIDS.'5
the T4-lymphocyte count (i.e., R2 = 0.2 1). Several series have compiled complication rates of sur-
gery in hemophiliacs operated on after 1960. Unfortu-Discussion nately differences among the series in types of surgery
Treatment center-based studies ofHIV- 1 prevalence in performed and relative frequency of type and severity of
hemophiliacs have revealed that 33% to 92% of subjects hemophilia make comparisons among the series difficult.
with hemophilia A and 14% to 52% of subjects with he- Bleeding complications have been reported to occur in
mophilia B are infected with HIV.'5 Seropositivity ofHIV- 4% to 23% of procedures, usually in the postoperative
1 among hemophiliacs is uniformly distributed through- period rather than during operation.'7-23 While one study
TABLE 4. T4 Lymphocyte Subset Analysis ofPatients at Time ofProcedure
HIV+
T4 Subset Analysis HIV- Pre-HIV+ Pre-AIDS AIDS
Patients (% total patients) 18 (78.3) 31 (81.6) 34 (85.0) 5 (83.3)
Procedures (% total procedures) 22 (71.0) 54 (80.6) 47 (73.4) 6 (85.7)
Procedures by T4 level
Less than 200 2 8 12 4
200-399 1 14 19 2
400-599 6 15 10 0
More than 600 13 17 6 0
Mean T4 level 622 518 335 139
Standard deviation, mean level 281 315 217 148
Mean T4 rank* 90 72 51 21
Standard deviation, mean rank 32 36 33 21
* All comparisons statistically significant (p < 0.05, Tukey's adjustment
for multiple comparisons employed): HIV- vs. pre-HIV+ p = 0.045;
HIV- vs. HIV+ pre-AIDS p < 0.001; HIV- vs. AIDS p < 0.001; pre-
HIV+ vs. HIV+ pre-AIDS p = 0.002; pre-HIV+ vs. AIDS p = 0.001;
HIV+ pre-AIDS vs. AIDS p = 0.045).
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noted a decrease in the incidence of hemorrhagic com-
plications with the use ofvigorous clotting factor concen-
tration,22 another did not.'8 The incidence of postopera-
tive wound infections in these series has been reported to
vary from 0% to 1%.17,18,23
Eighty-three hemophiliacs in our series underwent 169
procedures with an overall wound infection rate of 1.2%.
Dental extractions were included in our data because
multiple teeth were usually removed at each procedure
(mean, 4.3), these extractions represented a potential site
for wound infection, and dental problems are common
in HIV- 1-infected persons. There was no significant dif-
ference in wound infection rates between the HIV-positive
and HIV-negative patients. This overall rate of wound
infection is similar to rates reported in the literature after
surgery in hemophiliacs.'7"1'23 Furthermore this rate is
similar to the reported rate for clean surgery and occurred
despite an overall 17% incidence ofdocumented bleeding
complications. Our incidence of bleeding complications
in hemophiliacs is similar to that reported by others and
occurred despite the routine use ofprophylactic and ther-
apeutic factor replacement during the period of study.
Patients with AIDS are at increased risk of bacterial
infection. Atypical mycobacteria has been diagnosed in
8% to 29% of AIDS patients during the course of their
illness24 and M. tuberculosis in 5% to 10%. 6-10 In most
cases infection with M. tuberculosis preceeds development
of AIDS.6-'0 Case reports and uncontrolled series have
suggested that patients with AIDS or ARC commonly
develop bacterial sepsis25-29 and bacterial infections in-
volving the respiratory tract,3032 gastrointestinal tract,30'33
and skin.34 Bacterial pathogens reported associated with
AIDS have included Salmonella, Listeria, Streptococcus
pneumoniae, Hemophilus influenzae, Branhamella ca-
tarrhalis, Campylobacter jejuni, Campylobacter-like or-
ganisms, and Shigella.'2
Only limited data are available that indicate whether
HIV-I-infected patients who have not progressed to AIDS
are at increased risk of bacterial infection. Unusually se-
vere Salmonella infection, often associated with bacter-
emia and relapse despite appropriate therapy, has been
noted before or coincident with the diagnosis ofAIDS.35'36
Bacterial pneumonia has been reported to occur more
frequently in HIV-infected intravenous drug abusers
compared to noninfected controls.37 An increase in the
incidence ofpneumococcal bacteremia has been noted in
patients at risk of HIV-1 infection but without clinical
AIDS or ARC.38 Infectious eczemoid dermatitis was
shown to be significantly more common in HIV-1-in-
fected patients as compared with HIV- 1-negative high-
risk persons or controls.39
Despite the evidence suggesting that patients with ARC
or AIDS are at increased risk of bacterial infection, an
increased risk ofwound infection after invasive procedures
has not been described. This may be because the cellular
immune dysfunction caused by HIV- 1 is different from
the granulocyte and antibody deficiencies most often as-
sociated with an increased risk of wound infection. Al-
ternatively adequate numbers of patients with ARC or
AIDS undergoing invasive procedures have not been an-
alyzed. Two reported series of lymph node biopsies in
patients with ARC or AIDS revealed wound infection rates
of 0%40 and 2.5%.41 In two series of HIV-1-infected pa-
tients undergoing splenectomy for thromocytopenic pur-
pura, wound infections were noted in 1 of 15 patients
(6.7%)42 and in none of 11 patients (0%).43 Despite the
low incidence of wound infections in these series, the
postoperative mortality rate for HIV-1-infected patients
who have progressed to AIDS may be high. Patients with
AIDS requiring emergency intra-abdominal surgery have
been reported to have a 6-month survival rate ofless than
50%.44 AIDS patients undergoing anorectal surgery have
been reported to have a rate of poor healing of 88% and
a 16% rate of major complications.46 The morbidity and
mortality ofsurgery in patients with AIDS deserves further
study because approximately 18% to 24% ofpatients with
ARC or AIDS require surgical procedures.44'47
The decision to perform an invasive procedure must
always be analyzed on the basis of the risk-benefit ratio
for the patient and an informed decision by the patient
and physician. As with other patients, the decision to per-
form an invasive procedure on an HIV-1-positive indi-
vidual should be based, in part, on the risks and benefits
of the procedure. Our controlled series demonstrated
similar risks for postoperative wound infections between
HIV- 1-infected and uninfected hemophiliacs. While the
number of operations in patients who had progressed to
AIDS was small, this group also did not have an increased
incidence of postoperative wound infections. Although
T4-lymphcyte counts were lower in HIV- 1-infected com-
pared with noninfected hemophiliacs, they did not predict
an increased susceptibility to wound infections. Although
our data was derived from a study of hemophiliacs, we
believe it is likely to be applicable to HIV- 1-infected per-
sons who have acquired infection via intravenous drug
abuse or heter- or homosexual transmission. Despite the
frequent occurrence of wound bleeding and/or hemato-
mas, events that predispose to wound infections, the rate
of wound infections in both our HIV-1-infected and
noninfected subgroups was within commonly accepted
surgical standards.
Published series of surgical procedures among patients
with ARC and AIDS have been relatively small. The post-
operative morbidity and mortality rates among these pa-
tients, particularly among those with gastrointestinal
complications ofARC or AIDS, are substantially higher
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than those of the general population. Among asymptom-
atic HIV- 1-positive patients in our series, the operative
(30-day) mortality rate was 1.7%, while among HIV-1-
positive patients with AIDS it was 29%. Additional studies
will be needed to further define the postoperative mortality
in patients with AIDS because our data was based only
on seven operations in the patient group.
Because there is no increased risk of operation in HIV-
1-infected patients who do not have AIDS, screening all
patients before surgery would not provide additional use-
ful information in assessing patient risk-of a postoperative
wound infection. Considering the extent of the HIV-
epidemic, however, further study of the outcome and
complications of invasive procedures in patients with all
stages and manifestations of HIV- 1 infection is warranted.
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